The number of deaths from throat cancer of the uterus has decreased to zero for young women who received the HPV vaccine in England

Vaccine Linked to Significant Reduction in Cervical Cancer Deaths in England

Analysis conducted by The Lancet indicates that approximately 200 lives have been saved in England due to the human papillomavirus (HPV) vaccine. The findings stem from a landmark study initiated in 2008, when girls were administered the vaccine at age 12, as reported by the BBC. Between 2020 and 2024, a sustained period of five years, no deaths attributable to cervical cancer were recorded in women aged 20 to 24.

Had the vaccine not been implemented, estimates suggest approximately 23 deaths could have occurred within this demographic. Professor Peter Sasieni, head of the University of Queen Mary, commented on the results, stating, “It is incredible to think that one dose can eliminate a certain type of cancer.”

The research highlights the effectiveness of the vaccine in preventing HPV-related cancers. Ongoing monitoring and further studies are expected to continue evaluating the long-term impact of the vaccine program on reducing deaths from cervical cancer.

The data underscores the potential of preventative medicine in combating serious health conditions.

Topics: #vaccine #cancer #deaths